SMC HEALTHCARE

Specialized Medical Company

4019StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operating Summary
Revenue	406.91M	382.69M	379.96M	368.90M	327.07M
Cost of Revenue	323.31M	280.94M	278.05M	274.58M	305.91M
Gross Profit	83.60M	101.75M	101.91M	94.32M	21.15M
SG&A	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Expenses	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Income	71.83M	73.90M	48.58M	40.67M	31.43M
Interest Expense	-4.92M	-12.39M	-13.02M	-12.15M	-5.68M
Other Income/Expense	7.21M	6.98M	2.56M	2.61M	2.63M
Pretax Income	134.75M	68.49M	38.12M	31.14M	28.39M
Income Tax	0.77M	2.25M	1.76M	1.50M	2.23M
Net Income	133.98M	66.25M	36.36M	29.64M	26.16M
EBITDA	87.47M	90.07M	64.07M	55.83M	47.28M
EBIT	71.83M	73.90M	48.58M	40.67M	31.43M
EPS (Basic)	0.54	0.26	0.15	0.12	0.10
EPS (Diluted)	0.54	0.26	0.15	0.12	0.10
Margins & Efficiency
Gross Margin %	+20.5%	+26.6%	+26.8%	+25.6%	+6.5%
EBITDA Margin %	+21.5%	+23.5%	+16.9%	+15.1%	+14.5%
Net Margin %	+32.9%	+17.3%	+9.6%	+8.0%	+8.0%
Revenue & Income
Revenue	406.91M	382.69M	379.96M	368.90M	327.07M
Revenue Growth (YoY)	+24.4%	-2.2%	+6.6%	+1.6%	-12.8%
Gain (Loss) on Sale of Assets	60.63M	—	—	—	—
Expenses & Provisions
Cost of Revenue	323.31M	280.94M	278.05M	274.58M	305.91M
Selling, General & Admin	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Expenses	11.77M	27.85M	53.33M	53.65M	-10.28M
Interest Expense	-4.92M	-12.39M	-13.02M	-12.15M	-5.68M
Other Non Operating Income (Expenses)	7.21M	6.98M	2.56M	2.61M	2.63M
D&A For EBITDA	15.64M	16.17M	15.49M	15.15M	15.85M
Profitability & Returns
Gross Profit	83.60M	101.75M	101.91M	94.32M	21.15M
Gross Margin	+20.5%	+26.6%	+26.8%	+25.6%	+6.5%
EBIT	71.83M	73.90M	48.58M	40.67M	31.43M
EBIT Margin	+17.7%	+19.3%	+12.8%	+11.0%	+9.6%
EBITDA	87.47M	90.07M	64.07M	55.83M	47.28M
EBITDA Margin	+21.5%	+23.5%	+16.9%	+15.1%	+14.5%
EBT Excluding Unusual Items	74.12M	68.49M	38.12M	31.14M	28.39M
Pretax Income	134.75M	68.49M	38.12M	31.14M	28.39M
Operating Income	71.83M	73.90M	48.58M	40.67M	31.43M
Operating Margin	+17.7%	+19.3%	+12.8%	+11.0%	+9.6%
Profit Margin	+32.9%	+17.3%	+9.6%	+8.0%	+8.0%
Net Income	133.98M	66.25M	36.36M	29.64M	26.16M
Net Income to Common	133.98M	66.25M	36.36M	29.64M	26.16M
Net Income Growth	+412.2%	+12.4%	-28.6%	-39.8%	-55.7%
Income Tax Expense	0.77M	2.25M	1.76M	1.50M	2.23M
Effective Tax Rate	+0.6%	+3.3%	+4.6%	+4.8%	+7.9%
Per Share & Capital
EPS (Basic)	0.54	0.26	0.15	0.12	0.10
EPS (Diluted)	0.54	0.26	0.15	0.12	0.10
EPS Growth	+412.2%	+12.4%	-28.6%	-39.8%	-84.9%
Shares Change (YoY)	—	—	—	—	1.94
Shares Outstanding (Basic)	250.00M	250.00M	250.00M	250.00M	250.00M
Shares Outstanding (Diluted)	250.00M	250.00M	250.00M	250.00M	250.00M
Free Cash Flow	116.58M	84.97M	-71.39M	98.13M	217.75M
Free Cash Flow Margin	+28.7%	+22.2%	-18.8%	+26.6%	+66.6%
Free Cash Flow Per Share	0.47	0.34	-0.29	0.39	0.87
Payout Ratio	—	—	—	—	+382.3%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operating Summary
Revenue	406.91M	382.69M	379.96M	368.90M	327.07M
Cost of Revenue	323.31M	280.94M	278.05M	274.58M	305.91M
Gross Profit	83.60M	101.75M	101.91M	94.32M	21.15M
SG&A	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Expenses	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Income	71.83M	73.90M	48.58M	40.67M	31.43M
Interest Expense	-4.92M	-12.39M	-13.02M	-12.15M	-5.68M
Other Income/Expense	7.21M	6.98M	2.56M	2.61M	2.63M
Pretax Income	134.75M	68.49M	38.12M	31.14M	28.39M
Income Tax	0.77M	2.25M	1.76M	1.50M	2.23M
Net Income	133.98M	66.25M	36.36M	29.64M	26.16M
EBITDA	87.47M	90.07M	64.07M	55.83M	47.28M
EBIT	71.83M	73.90M	48.58M	40.67M	31.43M
EPS (Basic)	0.54	0.26	0.15	0.12	0.10
EPS (Diluted)	0.54	0.26	0.15	0.12	0.10
Margins & Efficiency
Gross Margin %	+20.5%	+26.6%	+26.8%	+25.6%	+6.5%
EBITDA Margin %	+21.5%	+23.5%	+16.9%	+15.1%	+14.5%
Net Margin %	+32.9%	+17.3%	+9.6%	+8.0%	+8.0%
Revenue & Income
Revenue	406.91M	382.69M	379.96M	368.90M	327.07M
Revenue Growth (YoY)	+24.4%	-2.2%	+6.6%	+1.6%	-12.8%
Gain (Loss) on Sale of Assets	60.63M	—	—	—	—
Expenses & Provisions
Cost of Revenue	323.31M	280.94M	278.05M	274.58M	305.91M
Selling, General & Admin	11.77M	27.85M	53.33M	53.65M	-10.28M
Operating Expenses	11.77M	27.85M	53.33M	53.65M	-10.28M
Interest Expense	-4.92M	-12.39M	-13.02M	-12.15M	-5.68M
Other Non Operating Income (Expenses)	7.21M	6.98M	2.56M	2.61M	2.63M
D&A For EBITDA	15.64M	16.17M	15.49M	15.15M	15.85M
Profitability & Returns
Gross Profit	83.60M	101.75M	101.91M	94.32M	21.15M
Gross Margin	+20.5%	+26.6%	+26.8%	+25.6%	+6.5%
EBIT	71.83M	73.90M	48.58M	40.67M	31.43M
EBIT Margin	+17.7%	+19.3%	+12.8%	+11.0%	+9.6%
EBITDA	87.47M	90.07M	64.07M	55.83M	47.28M
EBITDA Margin	+21.5%	+23.5%	+16.9%	+15.1%	+14.5%
EBT Excluding Unusual Items	74.12M	68.49M	38.12M	31.14M	28.39M
Pretax Income	134.75M	68.49M	38.12M	31.14M	28.39M
Operating Income	71.83M	73.90M	48.58M	40.67M	31.43M
Operating Margin	+17.7%	+19.3%	+12.8%	+11.0%	+9.6%
Profit Margin	+32.9%	+17.3%	+9.6%	+8.0%	+8.0%
Net Income	133.98M	66.25M	36.36M	29.64M	26.16M
Net Income to Common	133.98M	66.25M	36.36M	29.64M	26.16M
Net Income Growth	+412.2%	+12.4%	-28.6%	-39.8%	-55.7%
Income Tax Expense	0.77M	2.25M	1.76M	1.50M	2.23M
Effective Tax Rate	+0.6%	+3.3%	+4.6%	+4.8%	+7.9%
Per Share & Capital
EPS (Basic)	0.54	0.26	0.15	0.12	0.10
EPS (Diluted)	0.54	0.26	0.15	0.12	0.10
EPS Growth	+412.2%	+12.4%	-28.6%	-39.8%	-84.9%
Shares Change (YoY)	—	—	—	—	1.94
Shares Outstanding (Basic)	250.00M	250.00M	250.00M	250.00M	250.00M
Shares Outstanding (Diluted)	250.00M	250.00M	250.00M	250.00M	250.00M
Free Cash Flow	116.58M	84.97M	-71.39M	98.13M	217.75M
Free Cash Flow Margin	+28.7%	+22.2%	-18.8%	+26.6%	+66.6%
Free Cash Flow Per Share	0.47	0.34	-0.29	0.39	0.87
Payout Ratio	—	—	—	—	+382.3%